Opinion: Everyone benefits when vaccinations are widespread
By Paul D. Witman, Jim Prior and Chris Njunge Just over two years into the COVID-19 pandemic, and well into the biggest surge, we find humanity both amazingly fortunate and still at significant risk. Vaccines, in many forms, from many sources, are generally safe and remarkably effective at reducing infection and transmission and minimizing illness. Read More →
Opinion: Supreme Court vaccine rulings hold more questions than answers for employers
By Ryan Haws On Jan. 13, as COVID-19 cases across the nation surged to seemingly omnipresent levels, a divided United States Supreme Court issued two key orders affecting President Joe Biden’s “Path Out of the Pandemic” action plan. The first order belatedly held that the Occupational Safety and Health Administration exceeded its authority with its Read More →
Our View: Deja vu as 2022 begins, but with some big differences
We begin 2022 as we ended 2021, with the newest variant of the virus dominating the headlines. As the Business Times goes to press on its first edition of the year, it is back to the future, as most meetings and live events have moved to virtual. Virtual meetings are a poor substitute for in-person, Read More →
Our View: Vaccines still our best weapon against COVID
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Our View: Vaccines are the way out of this COVID resurgence
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.